Abbreviations used in this paper: DCT, distal convoluted tubule; DVF, divalent-free; TRP, transient receptor potential; WMN, wortmannin.

INTRODUCTION
============

Transient receptor potential (TRP) channels are widespread and play many important functions, ranging from thermal, tactile, taste, osmolar and fluid flow sensing, and embryo development to epithelial Ca^2+^ and Mg^2+^ transport ([@bib12]; [@bib22]; [@bib2]). They are classified into TRPC, TRPV, TRPM, TRPP, TRPML, TRPA, and TRPN subfamilies ([@bib12]; [@bib22]; [@bib2]). The TRPV subfamily is named after the first mammalian member of the subfamily, vanilloid receptor 1 ([@bib22]; [@bib2]). TRPV5 and TRPV6 are highly Ca^2+^-selective TRP channels that mediate trans-epithelial Ca^2+^ transport in kidney and intestine ([@bib12]).

Intracellular Mg^2+^ is a cofactor for many enzymes and controls inward rectification of ion channels by causing voltage-dependent block of outward currents ([@bib33]; [@bib9]). Recently, intracellular Mg^2+^ has also been reported to regulate the activity of several TRP channels including TRPM6, TRPM7, and TRPV6 via a mechanism different from voltage-dependent block ([@bib23]; [@bib34]; [@bib42], [@bib43]). The intracellular free Mg^2+^ concentration in most mammalian cells is between 0.5 and 1 mM and changes only slightly in response to physiological stimuli ([@bib33]). TRPM7 is permeable to Mg^2+^ ([@bib37]). It is believed that Mg^2+^ ions entering cells through TRPM7 feedback on the channel to regulate its activity ([@bib37]). TRPV6 does not conduct Mg^2+^ in physiological conditions. The physiological role of intracellular Mg^2+^ regulation of TRPV6 is unknown.

PIP~2~ directly regulates inward rectifying K^+^ and other channels ([@bib11]). How membrane lipids alter channel function is an area of intense research interests. For many ion channels, direct interaction with PIP~2~ stabilizes channels in certain conformations ([@bib11]). By stabilization in one conformation, PIP~2~ modulates the responses of ion channels to regulators, such as GTP binding proteins, intracellular pH, Na^+^, ATP, etc. ([@bib14]; [@bib38]; [@bib39]; [@bib17]).

In this report, we show that intracellular Mg^2+^ causes a fast voltage-dependent block and a slower inhibition of TRPV5. We further show that PIP~2~ activates TRPV5 and decreases sensitivity of the channel to the Mg^2+^-induced slow inhibition. Hydrolysis of PIP~2~ via receptor activation of phospholipase C increases the sensitivity of TRPV5 to the Mg^2+^-induced slow inhibition. These results provide a novel mechanism for regulation of TRP channels by PLC-activating hormones by increasing the sensitivity to intracellular Mg^2+^.

MATERIALS AND METHODS
=====================

Molecular Biology and Cell Culture
----------------------------------

Nucleotide coding sequence of cDNAs for rabbit TRPV5 in pCDNA3 mammalian expression vector ([@bib47]) was used as template for site-directed mutagenesis using a commercial mutagenesis kit (QuickChange; Stratagene). Mutations were confirmed by sequencing. CHO-K1 clone (from American Type Culture Collection) were cultured in F12-K medium (GIBCO-BRL) containing 10% FCS. Cells (at ∼50% confluence) were cotransfected with cDNA for pEGFP (1 μg) plus cDNAs for wild-type or mutant TRPV5 (10 μg per 35 mM dish for cell-attached and inside-out recording; 3 μg per dish for whole-cell recording) using lipofectamine-plus transfection kits (GIBCO-BRL) as previously described ([@bib47], [@bib48]). About 24--48 h after transfection, cells were dissociated by limited trypsin treatment and placed in a chamber for recording. Transfected cells were identified using epi-fluorescent microscopy for recordings.

Electrophysiological Recordings
-------------------------------

Cell-attached, inside-out, and whole-cell recordings were performed using an Axopatch 200B patch-clamp amplifier (Axon Instruments) as described previously ([@bib47], [@bib48]). For cell-attached recordings, the pipette and bath solution contained (in mM) 140 NaAsp (sodium aspartate), 10 NaCl, 1 EDTA, 10 HEPES (pH 7.4), and 140 KAsp, 10 NaCl, 1 EDTA, 10 HEPES (pH 7.4), respectively. For cell-attached recordings shown in [Fig. 8](#fig8){ref-type="fig"} A, the pipette solution contained (in mM) 140 NaCl, 1 MgCl~2~, 1 CaCl~2~, and 10 HEPES (pH 7.4). For inside-out recordings, membrane patches were excised into a bath solution containing (in mM) 140 NaAsp, 10 NaCl, 10 HEPES (pH 7.4), 10 EDTA, and various amounts of MgCl~2~ titrated to the desired concentrations of ionized Mg^2+^ as specified. Bath solution was perfused at ∼200 μl per second. The volume of perfusion chamber and connecting tubing is ∼100 μl. Thus, it takes 2--3 s to exchange the bath solution. Concentrations of ionized Mg^2+^ were calculated using a computer program based on algorithms by Fabiato ([@bib6]) ([www.stanford.edu/\~cpatton/webmaxc/webmaxcE.htm](http://www.stanford.edu/~cpatton/webmaxc/webmaxcE.htm)). For whole-cell recordings, the initial pipette and bath solution contained (in mM) 140 NaAsp, 10 NaCl, 10 HEPES (pH 7.4), 10 EDTA, and 140 NaAsp, 10 NaCl, 1 EDTA, 10 HEPES (pH 7.4), respectively. For whole-cell recordings shown in [Fig. 9](#fig9){ref-type="fig"} B, the bath solution contained (in mM) 140 NaCl, 1 MgCl~2~, 1 CaCl~2~, and 10 HEPES (pH 7.4). Intracellular Mg^2+^ in whole-cell recording was altered by intrapipette perfusion of solutions containing (in mM) 140 NaAsp, 10 NaCl, 10 HEPES (pH 7.4), 10 EDTA, and various amount of MgCl~2~ titrated to the desired concentrations of ionized Mg^2+^ as specified. The intrapipette perfusion was performed via a capillary quartz tubing (flamed and pulled manually to outer and inner diameter ∼50 and 20 μm, respectively) placed within ∼200 μm of the tip of the opening ([@bib10]). Voltage protocol for each experiment was described in the individual figure. Currents were low-pass filtered at 1 kHz using an 8-pole Bessel filter, sampled every 0.1 ms (10 kHz) with Digidata-1300 interface and stored directly onto computer hard disk using pCLAMP9 software. Data were transferred to compact discs for long-term storage.

Data Analysis
-------------

Dose--response curves for inhibition of TRPV5 by intracellular Mg^2+^ and concentration of Mg^2+^ for half-maximal inhibition (IC~50~) were obtained by fitting relative currents (normalized to maximal currents; I/Imax) at different Mg^2+^ concentrations using the Sigma-Plot program according to equation I/Imax = IC~50~/IC~50~ + \[Mg^2+^\]. The fractional electrical distance of the Mg^2+^ binding site from the outer surface of the membrane (δ) was calculated according to equation IC~50~(*V*) = IC~50~(0)exp (2δ*FV*/*RT*) ([@bib26]), where IC~50~(*V*) and IC~50~(0) represent IC~50~ at the test voltage *V* and at 0 mV, respectively, and *R*, *T*, and *F* have their usual meanings. Current traces were fitted to a single or double exponential curve (as indicated) to analyze time constant (τ) for inhibition of currents by Mg^2+^. The on-rate constant (K~on~) for slow inhibition by Mg^2+^ was calculated according to the equation K~on~ = 1/τ\[Mg^2+^\]. Data are shown as mean ± SEM of number of observations. Statistical comparison was made using unpaired Student\'s *t* test.

RESULTS
=======

Multiple Effects of Intracellular Mg^2+^ on TRPV5: Slow Reversible Inhibition, Fast Voltage-dependent Block, and "Run-down" via Reduction of PIP~2~
---------------------------------------------------------------------------------------------------------------------------------------------------

### Effect One: Slow Reversible Inhibition

We studied TRPV5 channels expressed in Chinese hamster ovary (CHO) cells by cell-attached and inside-out patch-clamp recording ([Fig. 1](#fig1){ref-type="fig"} A). In cell-attached recording, TRPV5-expressing CHO cells exhibited the characteristic strongly inwardly rectifying Na^+^ currents ([@bib27]; [@bib13]; [@bib47]) ([Fig. 1](#fig1){ref-type="fig"} B, C/A). Inward (closed circles) and outward currents (open circles) both increased markedly when inside-out patch membranes containing TRPV5 channels were excised ([Fig. 1](#fig1){ref-type="fig"} B, I/O) into divalent-free (DVF) bath solutions. Exchanging DVF solutions with one that contains 1 mM Mg^2+^ caused inhibition of TRPV5 currents over tens of seconds ([Fig. 1, B and C](#fig1){ref-type="fig"}). Currents recovered upon reintroduction of DVF solutions. TRPV5 currents increased by a similar extent when inside-out membranes were excised into Mg^2+^-free bath solutions containing 0, 200, or 1,000 nM Ca^2+^ (unpublished data). Thus, most (if not all) of the increase in currents upon excision of inside-out membranes into DVF solutions is due to loss of inhibition by intracellular Mg^2+^. We refer to this inhibition by intracellular Mg^2+^ occurring over tens of seconds as "slow reversible inhibition" to distinguish it from the much faster (also reversible) voltage-dependent block described below.

![Multiple effects of intracellular Mg^2+^ on TRPV5. (A) Configuration and voltage protocol of recording. Voltage stimuli were applied every 10 s. Black and gray arrows indicate time points when inward and outward currents shown in [Fig. 1](#fig1){ref-type="fig"} B were taken, respectively. (B) Intracellular Mg^2+^ causes a fast reversible voltage-dependent block, a slow reversible inhibition, and an irreversible run-down of TRPV5 in inside-out membranes. See text for details. Inside-out patches were bathed in either DVF or 1 mM Mg^2+^-containing solution. C/A and I/O indicate cell-attached and inside-out. Application of PIP~2~ and 1 mM La^3+^ (La) in DVF solution are indicated. Time interval between data points (shown in circles) is 10 s. As described previously by us ([@bib47], [@bib48]), expression of TRPV5 in CHO cells is robust. We estimated that under our experimental condition each excised patch contains ∼50--150 channels. PIP~2~ reactivated run-down TRPV5 channels (i.e., currents recovered to \>50% of the level before run-down) in 54 out of 62 recordings. We did not observe significant background currents in inside-out membranes of mock-transfected cells either before or after PIP~2~ (inward \[−100 mV\] and outward \[+100 mV\] currents: −87 ± 32 pA and 117 ± 28 pA, respectively, before PIP~2~ vs. −135 ± 41 pA and 156 ± 48 pA, respectively, after PIP~2~; mean ± SEM, *n* = 6). (C) Ramp I-V curves of currents at indicated time points in B. Scale bars for X (40 ms) and Y axis (0.2 nA) are shown. Dotted line indicates 0 current. In the X axis, the time points corresponding to ramp potentials −100, 0, and +100 mV (from left to right) are indicated by three downward arrows, respectively. Inset shows I-V curves scaled up to the same peak current level.](200509314f1){#fig1}

### Effect Two: Voltage-dependent Block and Distinction from the "Slow Reversible Inhibition"

Intracellular free Mg^2+^ also causes reversible voltage-dependent block of TRPV5 occurring over a relatively much faster time course (in millisecond time scale; see [@bib13]; [@bib42]). The distinction between the above slow reversible inhibition occurring over tens of seconds and the voltage-dependent block by Mg^2+^ is rather evident from our results (see ramp I-V curves in [Fig. 1](#fig1){ref-type="fig"} C). First, as mentioned above, inward currents shown in [Fig. 1](#fig1){ref-type="fig"} B were measured at the end of 40-ms hyperpolarization (−100 mV) step (indicated by black arrow in voltage ramp protocol in [Fig. 1](#fig1){ref-type="fig"} A). At these time points, Mg^2+^ ions were completely dissociated (from channels) by the hyperpolarization ([Fig. 1](#fig1){ref-type="fig"} C) and thus did not exert voltage-dependent block on channels. Second, the kinetics of voltage-dependent block distinguishes itself from the slow reversible inhibition. The Mg^2+^-induced voltage-dependent block of TRPV5 was evident by the characteristic unblock during the −100 mV hyperpolarization step (indicated by "a" in [Fig. 1](#fig1){ref-type="fig"} C), block of outward current ("b"), shift of reversal potential toward more negative membrane potential ("c"), and steeper I-V near the reversal potential ("d") in the current--voltage (I-V) relationship curves ([Fig. 1](#fig1){ref-type="fig"} C). The scaled-up I-V curves of currents from 10, 20, and 30 s after application of Mg^2+^ (time point 2, 3, and 4, respectively; time point 1 is immediately before application of Mg^2+^) were superimposable ([Fig. 1](#fig1){ref-type="fig"} C, inset), indicating that voltage-dependent block reached its maximal effect immediately after application of intracellular Mg^2+^ while slow reversible inhibition gradually reached its maximum over 30--40 s ([Fig. 1, B and C](#fig1){ref-type="fig"}). Thus, intracellular Mg^2+^ causes distinct fast voltage-dependent block (occurring in ms time scale) and slower reversible inhibition of TRPV5 (in seconds to tens of seconds) (see [Fig. 6](#fig6){ref-type="fig"} for time constant measurements for both processes).

### Effect Three: "Run-down" via Reduction of PIP~2~

Membrane phospholipid PIP~2~ regulates function of many ion channels and transporters ([@bib11]). In inside-out membranes, a prolonged exposure of the cytoplasmic face to Mg^2+^ activates Mg^2+^-dependent lipid phosphatases and depletes PIP~2~ ([@bib14]; [@bib18]). Depletion of PIP~2~ causes an irreversible loss of activity ("run-down") of channels that are regulated by PIP~2~ ([@bib14]). For TRPV5, though each short exposure to Mg^2+^ solution caused reversible inhibition, repetitive exposures to 1 mM Mg^2+^ solutions led to progressive irreversible run-down of currents eventually ([Fig. 1](#fig1){ref-type="fig"} B). Application of exogenous PIP~2~ to inside-out membranes reactivated TRPV5 after its irreversible run-down by Mg^2+^ ([Fig. 1](#fig1){ref-type="fig"} B), suggesting that irreversible run-down of TRPV5 by intracellular Mg^2+^ is due to loss of PIP~2~ in the membrane and mechanistically different from the reversible voltage-dependent block and "slow inhibition" by Mg^2+^. Activation of a Ca^2+^-sensitive PLC by intracellular Ca^2+^ depletes PIP~2~ and leads to desensitization of TRPM8 channels ([@bib32]). We found that U-37122 (an inhibitor of PLC, 5--10 μM) did not prevent run-down of TRPV5 caused by prolonged exposure to Mg^2+^ (unpublished data), supporting that Mg^2+^-induced run-down is caused by activation of lipid phosphatase(s) rather than by activation of some Mg^2+^-sensitive PLC.

A monoclonal antibody against PIP~2~ ([@bib7]) interferes with PIP~2~ regulation of ion channels presumably by sequestering PIP~2~ in the membranes ([@bib14]). Application of anti-PIP~2~ antibody to the cytoplasmic face of inside-out membranes decreased TRPV5 currents ([Fig. 2](#fig2){ref-type="fig"} A). Currents recovered partially after extensive washout of the antibody ([Fig. 2](#fig2){ref-type="fig"} B). Polylysine, with its positively charged residues, has also been used to inhibit the activity of PIP~2~-activated ion channels through competing PIP~2~--channel interaction ([@bib14]; [@bib28]). We found that application of polylysine (average molecular weight 1 kD; 30 μg/ml) to the inside-out membranes inhibited TRPV5 by 89 ± 9% in 3 min (*n* = 5; unpublished data). Similar to application of PIP~2~, application of Mg-ATP after irreversible run-down in Mg^2+^ solutions reactivated TRPV5 ([Fig. 2](#fig2){ref-type="fig"} B). Mg-ATP presumably works by activating lipid kinases, including phosphoinositide 4-kinase to regenerate PIP~2~ in the membranes ([@bib14]; [@bib11]). Consistent with this idea, the reversal by Mg-ATP was blunted by an inhibitor of phosphoinositide 4-kinase wortmannin ([@bib24]) ([Fig. 2](#fig2){ref-type="fig"} B, WMN). Furthermore, Na-ATP did not reactivate TRPV5 (unpublished data). [Fig. 2](#fig2){ref-type="fig"} C shows I-V curves of currents at several indicated time points. These results provide compelling evidence for a critical role of membrane PIP~2~ in the function of TRPV5.

![PIP~2~ is critical for TRPV5 channel activity. (A) Anti-PIP~2~ antibody reduces TRPV5 currents in inside-out patches. Experiments were repeated five times with similar results. The average (mean ± SEM) inhibition by anti-PIP~2~ antibody was 88 ± 13% and 79 ± 14% for outward and inward currents, respectively. (B) A representative experiment showing long exposure of inside-out patches to Mg^2+^ causes run-down of TRPV5, which can be subsequently reactivated by Mg-ATP. // indicates 10 min break. The inhibition by Mg^2+^ shown here appears to be slower compared with that in [Fig. 1](#fig1){ref-type="fig"} B. This variability is likely due to differences in the configuration and accessibility of excised membranes to perfused bath solutions. Closed and open circles are currents at −100 and +100 mV, respectively. Similar results were observed in six separate experiments. In some experiments, Mg-ATP was applied together with WMN (10 μM). Gray triangles illustrate one such recording receiving Mg-ATP + WMN superimposed on one receiving the Mg-ATP alone. Similar results were observed in four separate experiments. Dimethyl sulfoxide (DMSO, vehicle for WMN, 0.5%) did not prevent reactivation by Mg-ATP (*n* = 4, not depicted). Of note is that wortmannin did not prevent recovery of currents from transient inhibition by Mg^2+^ (not depicted), indicating that the slow reversible inhibition is not due to regeneration of PIP~2~ from lipid kinases. (C) I-V curves of currents at indicated time points in B. In this experiment, voltage ramp from −100 to +100 mV was applied without a 40-ms step at −100 mV as indicated in [Fig. 1](#fig1){ref-type="fig"} A. Dotted line indicates 0 current. In the X axis, the time point corresponding to ramp potential 0 mV is indicated by upward arrow. The characteristic voltage-dependent block in trace 3 is due to free (ionized) Mg^2+^ (0.13 mM) present in the Mg-ATP solution.](200509314f2){#fig2}

Application of PIP~2~ to Inside-out Membranes Releases Mg^2+^-induced Slow Reversible Inhibition
------------------------------------------------------------------------------------------------

Activation of inward-rectifier K^+^ and other channels by PIP~2~ modulates the regulation of channels by other signaling pathways ([@bib11]). We examined whether PIP~2~ activation of TRPV5 alters its sensitivity to Mg^2+^-induced slow inhibition. We examined dose--response relationships for the intracellular Mg^2+^-induced slow reversible inhibition of TRPV5 in excised inside-out membranes before and after application of PIP~2~. As before, after reaching maximal currents in DVF solutions in inside-out membranes, TRPV5 currents were completely inhibited by a solution containing 1 mM Mg^2+^ ([Fig. 3](#fig3){ref-type="fig"} A). Currents recovered in DVF solutions. The concentration of Mg^2+^ for half-maximal inhibition (IC~50~) of the inward currents of TRPV5 was 0.11 ± 0.03 mM (mean ± SEM, *n* = 7; [Fig. 3](#fig3){ref-type="fig"} C, closed circles). Application of exogenous PIP~2~ to inside-out membranes in DVF solutions increased TRPV5 currents by 2.4 ± 0.3--fold (*n* = 8; see [Fig. 3](#fig3){ref-type="fig"} A for representative experiment), indicating a submaximal concentration of PIP~2~ present in the excised membranes. The application of PIP~2~ reduced the sensitivity of TRPV5 to the slow reversible inhibition by intracellular Mg^2+^. After PIP~2~, the inward currents of TRPV5 were partially inhibited by 1 mM Mg^2+^ but completely inhibited by 10 mM Mg^2+^ ([Fig. 3](#fig3){ref-type="fig"} A). Currents recovered in the DVF solution ([Fig. 3](#fig3){ref-type="fig"} A). The IC~50~ for the slow inhibition by Mg^2+^ was increased by ∼28-fold to 3.11 ± 0.25 mM (*n* = 8; [Fig. 3](#fig3){ref-type="fig"} C, open circles) after application of exogenous PIP~2~. The Mg^2+^-induced voltage-dependent block remains distinguishable from the slow reversible inhibition even after application of exogenous PIP~2~. As shown by the scaled-up I-V curves ([Fig. 3](#fig3){ref-type="fig"} B), voltage-dependent block was complete in 1 mM Mg^2+^ in the presence of PIP~2~ (i.e., I-V curves at time point 2 and 3 are superimposable, [Fig. 3](#fig3){ref-type="fig"} B). Yet, Mg^2+^-induced slow inhibition requires 10 mM Mg^2+^ over 30--40 s to reach its maximum (i.e., more inhibition occurred from time point 2 to time point 3 in [Fig. 3](#fig3){ref-type="fig"} A).

![PIP~2~ decreases the sensitivity to Mg^2+^-induced slow inhibition but not the voltage-dependent block. (A) Application of PIP~2~ in inside-out patches increases TRPV5 currents and reduces the sensitivity to inhibition by Mg^2+^. Voltage ramp protocol is same as in [Fig. 1](#fig1){ref-type="fig"}. Holding potential between ramps is 0 mV. (B) Scaled-up I-V curves of currents at indicated time points in A. (C) Dose--response curves of inhibition by Mg^2+^ in inside-out patches before (no PIP~2~) and after application of PIP~2~ (+PIP~2~). IC~50~ was obtained by fitting relative inward currents (inward currents at −100 mV normalized to maximal currents; I/Imax) at different Mg^2+^ concentrations according to the equation I/Imax = IC~50~/IC~50~ + \[Mg^2+^\].](200509314f3){#fig3}

Effect of Intracellular Mg^2+^ on TRPV5 in Whole Cell
-----------------------------------------------------

The concentration of PIP~2~ in the excised membranes is likely considerably lower than in the plasma membranes in vivo ([@bib25]). We further examined regulation of TRPV5 by intracellular Mg^2+^ using whole-cell recording ([Fig. 4](#fig4){ref-type="fig"} A), which resembles physiological plasma membrane conditions better than the inside-out membranes. Strongly inwardly rectifying Na^+^ currents were observed immediately after establishment of whole-cell recording in TRPV5-expressing cells (time point 1 in [Fig. 4](#fig4){ref-type="fig"} B and trace 1 in [Fig. 4](#fig4){ref-type="fig"} C) but not in mock-transfected CHO cells ([Fig. 4](#fig4){ref-type="fig"} D). Dialysis of the intracellular space with a DVF solution led to a large increase of whole-cell TRPV5 currents ([Fig. 4, B and C](#fig4){ref-type="fig"}). As reported previously ([@bib13]; [@bib47]), whole-cell TRPV5 currents exhibited slight outward rectification at membrane potentials \>+50 mV in the presence of extracellular EDTA ([Fig. 4](#fig4){ref-type="fig"} C, trace 3). Perfusion of the intracellular space with a solution containing 1 mM Mg^2+^ caused a large reversible inhibition on whole-cell TRPV5 currents ([Fig. 4, B and C](#fig4){ref-type="fig"}). Unlike in the inside-out recordings, run-down of TRPV5 by Mg^2+^ is rather infrequent in whole-cell recordings (\>90% of experiments show \>80% recovery upon changing from Mg^2+^ to DVF solutions) despite an average longer exposure of the cytoplasmic face of plasma membrane to Mg^2+^. Thus, run-down of TRPV5 via activation of lipid phosphatases (as observed in excised inside-out patches) is likely not a physiological action of intracellular Mg^2+^ (as in the conditions of whole-cell recording). Intracellular Mg^2+^ at concentrations ranging from 0.1 to 3 mM caused a dose-dependent inhibition of whole-cell TRPV5 currents ([Fig. 4](#fig4){ref-type="fig"} E). The IC~50~ for intracellular Mg^2+^ inhibition of TRPV5 channels in whole-cell recordings was 0.29 ± 0.02 mM (*n* = 11; [Fig. 4](#fig4){ref-type="fig"} F). This IC~50~ is between that for inside-out membranes before PIP~2~ (IC~50~: 0.11 mM) and after PIP~2~ (IC~50~: 3.11 mM), suggesting that PIP~2~ content in whole cell membranes is intermediate between the latter two inside-out membrane conditions.

![Regulation of TRPV5 by intracellular Mg^2+^ in whole-cell recording. (A) Alteration of intracellular Mg^2+^ in whole-cell recording using intrapipette perfusion. (B) Intracellular perfusion of Mg^2+^ (1 mM) in whole-cell recording inhibits TRPV5 reversibly. The Y axis is current density (nA/pF). Time bar for the X axis represents 4 min. (C) I-V curves of currents at indicated time points in B. (D) Time control of intracellular Mg^2+^ perfusion in mock-transfected CHO cells (transfected with GFP plasmid alone). The Y axis is current density (pA/pF). Time bar for the X axis represents 4 min. (E) Dose-dependent inhibition of whole-cell TRPV5 currents by Mg^2+^ (0--3 mM). Each experiment at a given Mg^2+^ concentration was performed as in [Fig. 4](#fig4){ref-type="fig"} B and inward currents were scaled to the same maximal (current at DVF solution; I/I~max~ = 1) and minimal level (current after La^3+^; I/I~max~ = 0). (F) Dose--response curve of Mg^2+^ inhibition in whole-cell recording (closed squares) vs. in inside-out patches before (closed circles; no PIP~2~) and after PIP~2~ (open circles; +PIP~2~). IC~50~ was calculated according to the equation I/Imax = IC~50~ /IC~50~ + \[Mg^2+^\]. I/Imax = relative currents normalized to maximal currents. The two curves for inside-out patches before and after PIP~2~ are from [Fig. 3](#fig3){ref-type="fig"} C.](200509314f4){#fig4}

Regulation of ion channels including inward rectifier K^+^ and TRP channels by PIP~2~ involves direct interaction with positively charged amino acids in the channels ([@bib11]; [@bib30]; [@bib32]). Recently, Rohács et al. reported that arginine-606 of the rabbit TRPV5 (corresponding to arginine-599 of the rat TRPV5) is critical for interaction with PIP~2~ ([@bib32]). We found that R606Q mutant was more sensitive to inhibition by intracellular Mg^2+^ in whole-cell recordings (IC~50~: 0.03 ± 0.01 mM for R606Q \[*n* = 4\] vs. 0.29 ± 0.02 mM for wild type, P \< 0.05; not depicted in [Fig. 4](#fig4){ref-type="fig"}). These results further support that PIP~2~ activation of TRPV5 releases intracellular Mg^2+^ inhibition of the channel.

Mg^2+^-induced Slow Reversible Inhibition Is Voltage Dependent
--------------------------------------------------------------

To examine membrane voltage sensitivity, whole-cell TRPV5 currents were measured in intracellular DVF solution and in a solution containing 0.3 mM Mg^2+^ at different holding potentials. The fraction of TRPV5 currents in 0.3 mM intracellular Mg^2+^ relative to maximal currents in DVF solution (I/Imax) increased with increasing membrane hyperpolarization ([Fig. 5](#fig5){ref-type="fig"} A). Voltage sensitivity for the intracellular Mg^2+^-induced slow reversible inhibition of TRPV5 is further supported by the finding in experiments using whole-cell recording that hyperpolarization of membrane holding potentials from 0 to −50 mV increased IC~50~ for Mg^2+^ from 0.29 to 0.79 mM ([Fig. 5](#fig5){ref-type="fig"} B). Voltage dependency of inhibition by Mg^2+^ can be viewed as Mg^2+^ binds to inhibit the channel within the membrane electrical field. The fractional electrical distance of the binding site from the outer surface of the membrane (δ) can be calculated according to equation IC~50~(*V*) = IC~50~(0)exp(2δ*FV*/*RT*) ([@bib26]), where IC~50~(*V*) and IC~50~(0) represent IC~50~ at the test voltage *V* and at 0 mV, respectively, and *R*, *T*, and *F* have their usual meanings. Our results reveal that Mg^2+^-induced slow inhibition of TRPV5 is owing to Mg^2+^ binding inside the channel at δ = 0.26.

![Voltage dependency of the Mg^2+^-induced slow reversible inhibition. (A) Whole-cell currents were recorded in DVF and 0.3 mM intracellular Mg^2+^ at different holding potentials (from +50 to −100 mV) as in [Fig. 4](#fig4){ref-type="fig"} B. Relative currents (I/I~max~, current at 0.3 mM Mg^2+^/current at DVF) were plotted against holding potentials (V~h~). (B) Dose--response curve of inhibition by Mg^2+^ at 0 and −50 mV holding potentials. Dose--response curves were performed as in [Fig. 4](#fig4){ref-type="fig"} B.](200509314f5){#fig5}

Time Constant Measurement Provides Further Support for Voltage Dependency for Mg^2+^-induced Slow Inhibition and its Distinction from Voltage-dependent Block
-------------------------------------------------------------------------------------------------------------------------------------------------------------

Up to now, our studies examine the regulation of TRPV5 by intracellular Mg^2+^ by perfusion of solutions containing different concentration of Mg^2+^. To avoid variability in the rate of perfusion and measure time constants for the Mg^2+^-induced voltage-dependent block and the slow inhibition, we recorded whole-cell currents using voltage jump protocol at fixed intracellular Mg^2+^ concentration (1 mM) ([Fig. 6](#fig6){ref-type="fig"} A). Membrane potential was held at −100 mV. At this hyperpolarized potential, TRPV5 is fully open (not inhibited by intracellular Mg^2+^) and conducts inward current (see [Fig. 1](#fig1){ref-type="fig"}). Stepping from −100 to +100 mV resulted in a fast (i.e., occurring in ms and reaching maximal inhibition in ∼50 ms) time-dependent inhibition of the channel (shown as decrease of outward current in [Fig. 6](#fig6){ref-type="fig"} A). This fast inhibition of currents (known as the Mg^2+^-induced voltage-dependent block) represents the time course of binding of intracellular Mg ^2+^ into the pore and contributes to inward rectification of currents through TRPV5 and TRPV6 channels ([@bib13]; [@bib42]). As shown by others ([@bib42]), the time course of voltage-dependent block could be fitted by two exponential terms. [Fig. 6](#fig6){ref-type="fig"} B shows the two exponential time constants for voltage-dependent block at +25, +50, and +100 mV, respectively. Beyond the fast voltage-dependent block occurring within the first 50 ms, outward currents further decreased in a much slower time course (occurring in seconds and reaching minimal current level in \<60 s) ([Fig. 6](#fig6){ref-type="fig"} C). The mean exponential time constant (τ) for the "Mg^2+^-induced slow inhibition" at +100 mV was 8.3 ± 1.1 s (mean ± SEM, *n* = 4) ([Fig. 6](#fig6){ref-type="fig"} D). The on-rate constant (K~on~) for slow inhibition by Mg^2+^ at +100 mV (K~on~ = 1/τ \[Mg^2+^\]) was estimated at 120 ± 14 s^−1^M^−1^ (mean ± SEM, *n* = 4). Outward currents remained relatively stable beyond the first 50 ms in the absence of intracellular Mg^2+^ (current level at 60 s = 91 ± 8% of that at 100 ms, *n* = 4; not depicted in [Fig. 6](#fig6){ref-type="fig"}). Consistent with voltage dependency of Mg^2+^-induced slow inhibition, time constant at +50 and +25 mV were 13.4 ± 1.2 s and 16.2 ± 0.4 s, respectively ([Fig. 6](#fig6){ref-type="fig"} D, each P \< 0.05 vs. time constant holding at +100 mV). These time constant values at +100, +50, and +25 mV are in agreement with the earlier observation that Mg^2+^-induced slow inhibition occurred over 30--40 s at 0 mV (see [Fig. 1](#fig1){ref-type="fig"}; taking into consideration reduced PIP~2~ content in inside-out patches and probably a few seconds of delay in delivery of Mg^2+^ by perfusion).

![Kinetics of Mg^2+^-induced voltage-dependent block (A and B) and slow inhibition (C and D). (A) Whole-cell recording was performed at fixed intracellular Mg^2+^ (1 mM). Holding potential was −100 mV. Test pulse to +100 mV is illustrated. Time course of outward current (at +100 mV) from peak current (∼1 ms after test potential) to the current level at 50 ms is shown. Dotted line represents double exponential fit to the current. (B) Fast (squares) and slow (circles) exponential time constant of decrease of outward current from peak current (∼1 ms) to 50 ms of test potentials (+25, +50, +100 mV, respectively). (C) Time course of decrease of outward current from 100 ms to 60 s after test potential to +100 mV. Dotted line represents single exponential fit to the current. (D) Exponential time constants of decrease of outward current between 100 ms and 60 s of test potentials (+25, +50, and +100 mV, respectively).](200509314f6){#fig6}

Mutation of Aspartate-542 Abolishes Mg^2+^-induced Slow Reversible Inhibition
-----------------------------------------------------------------------------

Acidic amino acids located in solvent-accessible region between the second intracellular loop (2^nd^ IC loop) and the proximal region of the intracellular COOH terminus (CT) of TRPV5 may be involved in the binding and slow reversible inhibition by intracellular Mg^2+^ ([Fig. 7](#fig7){ref-type="fig"} A). We mutated seven acidic amino acids within this region, one at a time, to neutral amino acid asparagine or glutamine and tested the sensitivity of each mutant to inhibition by Mg^2+^ in whole-cell recordings. We found that neutralization of aspartate-542 (D542N) in the putative pore region completely abolished the slow reversible inhibition of TRPV5 by intracellular Mg^2+^ ([Fig. 7, B and C](#fig7){ref-type="fig"}). In voltage jump experiment, currents through D542N mutant remained unchanged over 60 s at +100 mV (current level at 60 s = 89 ± 15% of that at 100 ms, *n* = 3; not depicted in [Fig. 7](#fig7){ref-type="fig"}), confirming that aspartate-542 is critical for Mg^2+^-induced slow inhibition. Neutralization of other aspartate or glutamate residues in this region had no significant effects on the slow reversible inhibition of TRPV5 by Mg^2+^ ([Fig. 7](#fig7){ref-type="fig"} D).

![Identification of amino acid of TRPV5 involved in Mg^2+^-induced slow inhibition. (A) Membrane topology of amino acids between the fourth transmembrane (TM4) segment and the proximal COOH terminus (Ct) of TRPV5. Amino acids in the preselectivity filter region likely form a pore helix structure similar to that of KcsA ([@bib5]; [@bib44]). The location of amino acids mutated is shown. (B) A representative experiment of D542N mutant (in whole-cell recording) showing no inhibition by 1 mM Mg^2+^. (C) Dose--response curves of inhibition by Mg^2+^ for D542N mutant and wild-type (WT) TRPV5. (D) Average inhibition by Mg^2+^ for WT and each mutant (mean ± SEM, *n* = 5--11 each). \* indicates P \< 0.05 vs. WT.](200509314f7){#fig7}

Aspartate-542 is believed to be a part of the selectivity filter of TRPV5 and a binding site for Mg^2+^-induced voltage-dependent block ([@bib27]; [@bib13]). Our findings indicate that Mg^2+^ binding to aspartate-542 not only causes voltage-dependent block but also the slow inhibition. This conclusion is further supported by the fact that the fractional electrical distance for the slow inhibition we measured in this study (δ = 0.26) is similar to that measured for voltage-dependent block (δ = 0.31) ([@bib26]).

Reduction of PIP~2~ Enhances Mg^2+^-induced Slow Reversible Inhibition of TRPV5 without Affecting Mg^2+^ Binding
----------------------------------------------------------------------------------------------------------------

To investigate the mechanism for PIP~2~ modulation of Mg^2+^-induced slow reversible inhibition of TRPV5, we tested whether PIP~2~ affects Mg^2+^ binding. The kinetics of Mg^2+^-induced slow inhibition and voltage-dependent block were studied using voltage jump experiments as in [Fig. 6](#fig6){ref-type="fig"}. Whole-cell recordings were performed in the presence of intracellular Mg^2+^ (1 mM). The extracellular bath solution contained thrombin + wortmannin (WMN) or vehicle. WMN inhibits phosphoinositide 4-kinase (a rate-limiting enzyme for synthesis of PIP~2~ from phosphatidylinositol and phosphatidylinositol-4-phosphate) to allow reduction of membrane PIP~2~ following receptor-mediated hydrolysis of PIP~2~ ([@bib24]). [Fig. 8](#fig8){ref-type="fig"} A shows representative single exponential fit to current traces in response to voltage jump from −100 to +100 mV in the presence of thrombin + WMN (labeled as Thr) or vehicle (Control). As expected for PIP~2~ releasing Mg^2+^-induced slow inhibition, reduction of membrane of PIP~2~ by incubating with thrombin and WMN decreased the time constants for inhibition at depolarized membrane potentials ([Fig. 8](#fig8){ref-type="fig"} B, P \< 0.05, +Thr vs. Control for all potentials). Interestingly, reduction of membrane PIP~2~ had no effects on the time constants for Mg^2+^-induced voltage-dependent block to the channel ([Fig. 8](#fig8){ref-type="fig"} C; time constants measured as in [Fig. 6](#fig6){ref-type="fig"} B).

![Effects of PIP~2~ hydrolysis on Mg^2+^-induced slow inhibition (A and B) and voltage-dependent block (C). (A) Whole-cell currents (between 100 ms and 60 s; at 1 mM intracellular Mg^2+^) in response to voltage jump from −100 mV holding potential to depolarized test potentials were measured as in [Fig. 6](#fig6){ref-type="fig"} C. Cells were incubated with vehicle (Control) or thrombin + WMN (+Thr) in the extracellular bath for 10 min before patch-clamped for whole-cell recordings. Shown are representative single exponential fits to currents for Control (black curve) or +Thr (gray curve). Relative current level corresponding to 1/*e* (*e*, the base of natural logarithms) of the maximal current is shown. (B) Time constants of Mg^2+^-induced slow inhibition at +25, +50, +100 mV for Control and +Thr. \* indicates P \< 0.05 +Thr vs. Control. (C) Time constants of Mg^2+^-induced voltage-dependent block (as in [Fig. 6, A and B](#fig6){ref-type="fig"}) at +25, +50, +100 mV for Control and +Thr.](200509314f8){#fig8}

Enhancement of Mg^2+^-induced Slow Inhibition as a Mechanism for PLC-coupled Receptor Regulation TRPV5-mediated Ca^2+^ Entry
----------------------------------------------------------------------------------------------------------------------------

The physiological function of TRPV5 is to allow Ca^2+^ entry through the apical membrane for transepithelial transport of Ca^2+^ in kidney and intestine ([@bib12]). We next examined the effects of PIP~2~ hydrolysis induced by receptor activation of PLC on TRPV5 functioning as a Ca^2+^-permeable channel. In the following cell-attached recordings, the pipette solution contained (in mM) 140 NaCl, 1 MgCl~2~, and 1 CaCl~2~. Because of the anomalous mole fraction behavior, TRPV5 conducts Ca^2+^ exclusively in this physiological solution ([@bib41]). CHO cells express endogenous receptors for thrombin ([@bib4]). Activation of PLC by endogenous thrombin receptors in CHO cells was verified by the release of Ca^2+^ from intracellular stores (unpublished data). Thrombin was applied to the patch membrane via intrapipette perfusion ([Fig. 9](#fig9){ref-type="fig"} A). The bath solution contained vehicle or wortmannin.

![Effect of PIP~2~ hydrolysis on the Mg^2+^-induced slow inhibition. (A) Effect of thrombin plus/minus wortmannin on TRPV5 in cell-attached recording. The top left panel shows cell-attached configuration for recording TRPV5-mediated Ca^2+^ currents. See text for the pipette solution. Voltage stimuli (step to −100 mV for 40 ms and ramp from −100 to +100 mV ramp over 200 ms) were applied every 2 s from +50 mV holding potential. Holding at +50 mV prevents Ca^2+^ entry and the Ca^2+^-dependent inactivation. Thrombin (Thr, 1 U/ml) was applied to the patch membrane by intrapipette perfusion. WMN (10 μM) or vehicle (0.5% DMSO) was applied to the extracellular bath in cells expressing TRPV5 5--10 min before addition of thrombin. The bottom panel shows inward currents (at −100 mV) normalized to the initial current (I/Imax). The top right panel shows ramp I-V curves at indicated time points. (B) Dose--response curve of inhibition by Mg^2+^ before and after membrane PIP~2~ hydrolysis. Whole-cell TRPV5-mediated Ca^2+^ currents were recorded in a bath solution containing (in mM) 140 NaCl, 1 MgCl~2~, 1 CaCl~2~, and 10 HEPES (pH 7.4). Intracellular Mg^2+^ (0 to 3 mM) was altered by intrapipette perfusion. Cells expressing TRPV5 were incubated with a bath solution containing either vehicle (closed circles) or WMN + Thr (open circles) for 5--10 min before patching for whole-cell recording. Voltage protocol and holding potential are as in the cell-attached experiment.](200509314f9){#fig9}

In cell-attached recording, application of thrombin (Thr) in the absence of WMN decreased TRPV5 Ca^2+^ currents transiently (by 43 ± 8% in 90 s, *n* = 5, P \< 0.05 vs. control without thrombin) ([Fig. 9](#fig9){ref-type="fig"} A). Presumably due to desensitization of receptors and de novo synthesis of PIP~2~ via phosphoinositide 4-kinase, TRPV5 currents recovered at least partially over 3--4 min in the absence of wortmannin. In the presence of wortmannin, thrombin caused a persistent reduction of TRPV5 currents by 85 ± 5% in 90 s (*n* = 6, P \< 0.05 vs. thrombin alone). As controls, TRPV5 currents did not change significantly without thrombin (decreased by 8 ± 7% over 90 s, *n* = 4; WMN alone in [Fig. 9](#fig9){ref-type="fig"} A). The effects of PIP~2~ hydrolysis on dose-dependent inhibition by Mg^2+^ of TRPV5-mediated Ca^2+^ currents were examined by whole-cell recording ([Fig. 9](#fig9){ref-type="fig"} B). The IC~50~ for Mg^2+^ inhibition of TRPV5-mediated Ca^2+^ currents were 0.61 ± 0.12 mM (*n* = 5) and 0.11 ± 0.08 (*n* = 5) for control cells (treated with vehicle) and cells treated with thrombin and wortmannin, respectively (P \< 0.05). The concentration of the intracellular free Mg^2+^ in the cell-attached recording is estimated at ∼0.5 mM ([@bib33]). These results support the hypothesis that an increase in sensitivity to intracellular Mg^2+^ is important for physiological regulation of TRPV5-mediated Ca^2+^ entry by PLC-activating hormones.

DISCUSSION
==========

Many TRP channels are downstream of G protein--coupled receptors and PLC (for review see [@bib2]; [@bib31]). Thus, TRP channels may be regulated by G protein--coupled receptors via inositol-1,4,5-trisphosphate and/or diacylglycerol, products of PIP~2~ breakdown catalyzed by PLC ([@bib2]; [@bib31]). Several TRP channels are also directly regulated by PIP~2~ ([@bib3]; [@bib8]; [@bib35]; [@bib19]; [@bib18]; [@bib32]). Therefore, an additional mechanism for PLC to control TRP channels is via reduction of PIP~2~ content ([@bib3]; [@bib35]; [@bib18]). However, the reduction of PIP~2~ in the plasma membrane from physiological stimulation of PLC may not be sufficient to alter the activity of channels if the affinity of channels for PIP~2~ is relatively high ([@bib15]). In the present study, we find that PIP~2~ activates TRPV5 and that activation of TRPV5 by PIP~2~ decreases the sensitivity of TRPV5 to inhibition by intracellular Mg^2+^ (see working model in [Fig. 10](#fig10){ref-type="fig"}). Hydrolysis of PIP~2~ by receptor activation of PLC increases the sensitivity to the inhibition by Mg^2+^. These results provide a novel mechanism for regulation of TRP channels by PLC-activating hormones by increasing the sensitivity to intracellular Mg^2+^.

![A working model showing the relationships of three different effects of Mg^2+^ on TRPV5. Binding of intracellular Mg^2+^ to D542 of TRPV5 causes a fast (in ms time scale) voltage-dependent block. Prolonged binding to the same site by Mg^2+^ (e.g., 10 s) leads to slow inhibition, which is likely due to conformational changes of the channel. The slow inhibition is also voltage dependent. Membrane PIP~2~ stabilizes TRPV5 in open conformation. PIP~2~ interaction with TRPV5 does not affect Mg^2+^ binding but prevents Mg^2+^-induced conformational changes. Mg^2+^ causes run-down by activating lipid phosphatases. However, run-down is probably not a physiological effect of Mg^2+^ as it occurs predominantly in excised inside-out membranes. Hydrolysis of PIP~2~ by activating PLC-coupled receptors sensitizes TRPV5 to inhibition by intracellular Mg^2+^. \* indicates that time constant for Mg^2+^-induced slow inhibition of TRPV5 is shorter in PIP~2~-reduced (e.g., 5 s) than in PIP~2~-repleted state (e.g., 10 s). For comparison, Mg-induced slow inhibition has also been reported for TRPV6, TRPM6, and TRPM7 ([@bib23]; [@bib34]; [@bib42], [@bib43]). Mg^2+^-induced voltage-dependent block contributes to inward rectification of many channels, including inward-rectifier K^+^ channels and TRPV5 and 6. Mg^2+^ would presumably cause run-down on all PIP~2~-regulated ion channels.](200509314f10){#fig10}

The cytosolic free Mg^2+^ concentration in most mammalian cells is between 0.5 and 1 mM ([@bib33]). The IC~50~ for the slow inhibition (0.79 mM) at −50 mV (near the physiological resting membrane potential) suggests that intracellular Mg^2+^ is an important physiological regulator of TRPV5 function in vivo. The intracellular free Mg^2+^ concentration changes only slightly in response to physiological stimuli ([@bib33]). However, the dramatic shift in Mg^2+^ sensitivity by PIP~2~ will provide amplification for regulation of TRPV5 by intracellular Mg^2+^ and PLC-activating hormones. One such example is the inhibition of calcium transport in the distal renal tubules by prostaglandin E~2~ through activation of phospholipase C via EP~1~ receptors ([@bib12]).

Besides TRPV5 and TRPV6, intracellular Mg^2+^ has recently been recognized as an important regulator of TRPM6 and TRPM7 channels ([@bib23]; [@bib34]; [@bib43]). TRPM7 (also known as magnesium-inhibited cation channel \[MIC\]; [@bib16]; [@bib29]) is a ubiquitous channel important for cellular uptake of magnesium and cell viability ([@bib37]). Magnesium ions entering cells through TRPM7 feedback on the channel to regulate its activity ([@bib37]). TRPM7 is also regulated by PIP~2~ ([@bib35]). Whether PIP~2~ also modulates Mg^2+^ sensitivity for TRPM7 is unknown at present.

TRPV5 does not conduct Mg^2+^ in physiological conditions. However, TRPM6 (a close homology of TRPM7) is a Mg^2+^-permeable channel responsible for magnesium transport in epithelial tissues ([@bib36]; [@bib45]; [@bib43]). Both TRPV5 and TRPM6 are present in the distal convoluted tubule (DCT) cells ([@bib12]; [@bib36]; [@bib45]; [@bib43]), which are key cells responsible for transcellular reabsorption of magnesium and calcium in the kidney ([@bib40]). Many diseases with reduced Mg^2+^ transport in the DCT exhibit increased Ca^2+^ transport. These diseases include genetic diseases such as familial hypomagnesemia with hypocalciuria and Gitelman\'s disease ([@bib46]) and acquired diseases such as cis-platinum toxicity ([@bib21]). Our present finding that intracellular Mg^2+^ negatively regulates TRPV5 raises the possibility that a decrease in Mg^2+^ influx through TRPM6 leads to an increase in Ca^2+^ influx through TRPV5/TRPV6 in DCT cells, providing a possible molecular explanation for this disease phenotype. It should be noted that patients with mutations of TRPM6 develop hypocalcemia ([@bib36]; [@bib45]), rather than hypercalcemia as would be expected from an increase in Ca^2+^ reabsorption in DCT cells alone. Hypocalcemia in these patients is believed secondary to parathyroid failure from severe magnesium wasting and hypomagnesemia ([@bib1]).

Intracellular Mg^2+^ regulates inward rectification of ion channels including inward rectifier K^+^ channels and TRPV5 and TRPV6 channels via voltage-dependent block ([@bib20]; [@bib13]; [@bib42]). In the present study, we report that intracellular Mg^2+^ regulates TRPV5 additionally via a mechanism likely involving conformational change of the protein ([Fig. 10](#fig10){ref-type="fig"}). We refer to this additional inhibition by Mg^2+^ as slow reversible inhibition to distinguish from the faster voltage-dependent block. A similar dual regulation of TRPV6 by intracellular Mg^2+^ via voltage-dependent block and a slower inhibition has recently been reported ([@bib42]).

Aspartate-542 of TRPV5 is a part of the selectivity filter critical for permeation of Ca^2+^ ions and a binding site for Mg^2+^-induced voltage-dependent block of Ca^2+^ and Na^+^ currents ([@bib27]; [@bib13]). Our findings suggest that binding of intracellular Mg^2+^ to aspartate-542 in the selectivity filter inhibits TRPV5 via at least two separate but interrelated mechanisms. The first mechanism is by voltage-dependent block. In this mechanism, Mg^2+^ ions bind and occlude the channel pore, preventing ion permeation. This inhibition by blocking of channel pore occurs as soon as Mg^2+^ enters and binds the selectivity filter driven by membrane depolarization and reverses quickly by membrane hyperpolarization. This is similar to voltage-dependent block of inwardly rectifying K^+^ channels and other channels by Mg^2+^, polyamines, and other charged blockers ([@bib9]). Binding of Mg^2+^ to the selectivity filter of TRPV5 for a longer duration, however, leads to the second mechanism of inhibition: the slow reversible inhibition. The slow reversible inhibition develops over 30--40 s and is not reversed by transient unbinding of Mg^2+^ ions during intermittent membrane hyperpolarization from voltage ramp applied every 10 s The exact mechanism for the slow inhibition remains unknown, but likely involves conformational change(s) of the channel protein.

Our results also shed light on the mechanism by which PIP~2~ alters the sensitivity of TRPV5 to slow inhibition by Mg^2+^. PIP~2~ activates many ion channels directly by affecting their structure ([@bib11]). We find that PIP~2~ activates TRPV5 in the absence of intracellular Mg^2+^ ([Fig. 1](#fig1){ref-type="fig"} B). PIP~2~ also regulates D542N, a Mg^2+^ binding site mutant (unpublished data). Thus, activation of TRPV5 by PIP~2~ does not require its regulation by intracellular Mg^2+^. However, activation of TRPV5 by PIP~2~ decreases the sensitivity of TRPV5 for intracellular Mg^2+^-induced slow inhibition. PIP~2~ does so without affecting Mg^2+^ binding to TRPV5 ([Fig. 8](#fig8){ref-type="fig"} C). We suggest that PIP~2~ desensitizes TRPV5 to Mg^2+^-induced slow inhibition by stabilizing channel in an open conformation and prevents the conformational change induced by binding of Mg^2+^.

It is known that ion binding may alter the structure of selectivity filter of ion channels. For example, occupancy of K^+^ ions in the selectivity filter slows the rate of C-type inactivation of voltage-gated K^+^ channels ([@bib49]). The crystal structure of the bacterial KcsA K^+^ channel reveals that presence of multiple K^+^ ions in the selectivity filter stabilizes the full open conformation ([@bib50]). Our present study provides an example of conformational changes of ion channels caused by binding of a pore blocker.
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